Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Microbot Medical Inc (MBOT)

3.25 +0.03 (+0.93%)

5/22/2017  11:22am

Open:

3.26

Pre. Close:

3.22

High:

3.30

Low:

3.20

Volume:

39,781

Market Cap:

88.57M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.66 - 3.77

3.77 - 3.86

Low:

2.97 - 3.05

3.05 - 3.13

Close:

3.09 - 3.23

3.23 - 3.36

Technical analysis  (as of: 2017-05-22 10:48:40 AM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 5.38     One year: 6.41

Support:

Support1: 3.17    Support2: 2.64

Resistance:

Resistance1: 4.60    Resistance2: 5.49

Pivot:

4.23

Moving Averages:

MA(5): 3.46     MA(20): 4.45

MA(100): 5.48     MA(250): 3.25

MACD:

MACD(12,26): -0.49     Signal(12,26,9): -0.36

%K %D:

%K(14,3): 2.89     %D(3): 2.58

RSI:

RSI(14): 19.43

52-Week:

High: 27.45  Low: 2.97  Change(%): 9.9

Average Vol(K):

3-Month: 101  10-Days 61

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MBOT has closed above bottom band by 6.5%. Bollinger Bands are 30% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 15 May 2017 11:26:15 GMT
Microbot Medical Inc. Reports First Quarter 2017 Financial Results and Recent ...

Fri, 16 Dec 2016 07:25:28 GMT
3.22

Tue, 29 Nov 2016 19:30:31 GMT
Microbot Medical Inc. MBOT (US: Nasdaq)

Thu, 12 Jan 2017 20:58:38 GMT
Microbot Medical: ~$250 Million Market Cap... Irrational Exuberance At Its Best

Wed, 17 Aug 2016 12:11:15 GMT
Stemcell Merger: Why It Happened

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

27.00

Shares Float (M)

4.32

% Held by Insiders

% Held by Institutions

Shares Short (K)

538

Shares Short Prior Month (K)

614

Stock Financials

EPS

-0.400

EPS Est. Current Year

-25.020

EPS Est. Next Year

-15.120

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.060

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-309.0

Return on Equity (ttm)

-1184.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.356

Qtrly Earnings Growth

Operating Cash Flow (M)

-0.79

Levered Free Cash Flow (M)

1.96

FoxReading.com

Valuation

P/E

-8.02

P/E Growth Ratio

P/BV

53.50

P/S

P/CF

-110.27

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.